Pfizer (NYSE:PFE) Updates FY 2023 Earnings Guidance
Pfizer (NYSE:PFE – Get Free Report) updated its FY 2023 earnings guidance on Wednesday. The company provided EPS guidance of 1.450-1.650 for the period, compared to the consensus EPS estimate of 1.560. The company issued revenue guidance of $58.0 billion-$61.0 billion, compared to the consensus revenue estimate of $58.8 billion. Pfizer also updated its FY […]
More Stories
Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $12.75
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that...
Golden Entertainment, Inc. (NASDAQ:GDEN) Receives $39.40 Average PT from Brokerages
Shares of Golden Entertainment, Inc. (NASDAQ:GDEN – Get Free Report) have been assigned an average recommendation of “Buy” from the...
Barclays Increases Smartsheet (NYSE:SMAR) Price Target to $50.00
Smartsheet (NYSE:SMAR – Free Report) had its price target lifted by Barclays from $45.00 to $50.00 in a report issued...
Ardelyx, Inc. (NASDAQ:ARDX) Given Consensus Recommendation of “Buy” by Analysts
Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) has earned a consensus rating of “Buy” from the eight ratings firms that...
Intercontinental Exchange, Inc. (NYSE:ICE) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of Intercontinental Exchange, Inc. (NYSE:ICE – Get Free Report) have been given a consensus rating of “Moderate Buy” by...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Rating of “Moderate Buy” from Analysts
AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five...